Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter study
L Bao, YT Wang, P Liu, MQ Lu, JL Zhuang… - …, 2024 - thelancet.com
Background Frail elderly patients with newly diagnosed multiple myeloma (NDMM) have
inferior survival and less benefit from high-dose therapies. This prospective study aimed to …
inferior survival and less benefit from high-dose therapies. This prospective study aimed to …
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic
J Carmichael, F Seymour, G McIlroy, S Tayabali… - Blood Cancer …, 2023 - nature.com
The COVID-19 pandemic has had global healthcare impacts, including high mortality from
SARS-CoV-2 infection in cancer patients; individuals with multiple myeloma (MM) are …
SARS-CoV-2 infection in cancer patients; individuals with multiple myeloma (MM) are …
Selection determines therapeutic effects: a retrospective analysis of the application of different frailty tools in elderly patients with multiple myeloma
Y Li, S Zhao, J Xu, J Zhang, J Wang, H Guo, L Liu… - Discover Oncology, 2024 - Springer
Objective The aim was to explore the effectiveness of the International Myeloma Working
Group Frailty Index (IMWG-FI), Mayo Score, UK Myeloma Research Alliance Risk Profile …
Group Frailty Index (IMWG-FI), Mayo Score, UK Myeloma Research Alliance Risk Profile …
Real-world outcomes with cumulative bortezomib dose and efficacy in the treatment of transplant-ineligible multiple myeloma with cyclophosphamide, bortezomib, and …
C Nie, H Lee, J Tay, P Duggan, S McCulloch… - … Myeloma and Leukemia, 2023 - Elsevier
Background Higher cumulative dose of bortezomib, a key component of Multiple Myeloma
(MM) treatment regimens, has been shown to improve outcomes in MM patients, but must be …
(MM) treatment regimens, has been shown to improve outcomes in MM patients, but must be …
[PDF][PDF] Delayed diagnosis resulting in increased disease burden in multiple myeloma
J Carmichael, F Seymour, G McIlroy, S Tayabali… - 2023 - pure-oai.bham.ac.uk
Multiple myeloma often presents with symptoms both vague and non-specific, creating a
diagnostic challenge. Consequently, the diagnosis of myeloma is frequently made via …
diagnostic challenge. Consequently, the diagnosis of myeloma is frequently made via …
Diagnostic delay in multiple myeloma: the legacy of the COVID-19 pandemic.
J Carmichael, F Seymour, G Mcilroy, S Tayabali… - 2022 - researchsquare.com
The COVID-19 pandemic has had global healthcare impacts, including high mortality from
SARS-CoV-2 infection in cancer patients; individuals with multiple myeloma (MM) are es …
SARS-CoV-2 infection in cancer patients; individuals with multiple myeloma (MM) are es …